Table 3.

Effect of polymorphisms rs11781886 and rs2228013 on total, low-grade, and high-grade prostate cancer risk in all participants of SELECT case–control cohort

PolymorphismHR (95% CIs)P
Total prostate cancer
 rs117818861.072 (0.967–1.188)0.1852
 rs22280130.953 (0.759–1.196)0.6773
Low grade
 rs117818861.076 (0.951–1.218)0.2463
 rs22280131.008 (0.771–1.318)0.9529
High grade
 rs117818861.099 (0.939–1.286)0.2390
 rs22280130.933 (0.654–1.329)0.6994